A mathematical modeling study suggests that ovarian cancer incidence could be reduced and healthcare savings boosted if women who have already completed their families were offered fallopian tube removal during any other suitable abdominal surgeries.
from Women's Health News -- ScienceDaily https://ift.tt/Unka90l
Friday, January 31, 2025
Study shows potential of resveratrol to aid fertility
A new study has highlighted the potential of resveratrol, a natural compound found in grapes, blueberries, and raspberries, to enhance female fertility. The systematic review found that resveratrol can improve the quantity and quality of egg cells, offering hope for new, less invasive fertility treatments.
from Women's Health News -- ScienceDaily https://ift.tt/YkU24pP
from Women's Health News -- ScienceDaily https://ift.tt/YkU24pP
Wednesday, January 29, 2025
An injectable hydrogel for local bone densification
Researchers have combined injections of a novel hydrogel with systemic osteoporosis drugs in rats, achieving rapid local increases in bone density. The results offer hope for future fracture prevention therapies in osteoporosis patients.
from Women's Health News -- ScienceDaily https://ift.tt/NyaVwlY
from Women's Health News -- ScienceDaily https://ift.tt/NyaVwlY
Routine brain MRI screening in asymptomatic late stage breast cancer patients
A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests that doctors may need to rethink current screening guidelines for detecting brain metastasis in patients without symptoms.
from Breast Cancer News -- ScienceDaily https://ift.tt/K9jfOJI
from Breast Cancer News -- ScienceDaily https://ift.tt/K9jfOJI
Inherited gene elevates prostate cancer risk in affected families
The inherited mutated gene WNT9B, which functions normally in embryonic prostate development, increases risk of adult prostate cancer, according to a new study.
from Breast Cancer News -- ScienceDaily https://ift.tt/GIkfdB9
from Breast Cancer News -- ScienceDaily https://ift.tt/GIkfdB9
Friday, January 24, 2025
Dissolving clusters of cancer cells to prevent metastases
Successful test in breast cancer patients: the active agent digoxin, a cardiac medication, dissolves clusters of circulating breast cancer cells in the blood, thus reducing the risk of metastases formation.
from Breast Cancer News -- ScienceDaily https://ift.tt/oz36fCY
from Breast Cancer News -- ScienceDaily https://ift.tt/oz36fCY
Dissolving clusters of cancer cells to prevent metastases
Successful test in breast cancer patients: the active agent digoxin, a cardiac medication, dissolves clusters of circulating breast cancer cells in the blood, thus reducing the risk of metastases formation.
from Women's Health News -- ScienceDaily https://ift.tt/oz36fCY
from Women's Health News -- ScienceDaily https://ift.tt/oz36fCY
Thursday, January 23, 2025
New combination immunotherapy for melanoma and breast cancer
A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod. This combination showed promising results in topically accessible tumors like melanoma and breast cancer models: The therapy led to the death of tumor cells at the treated sites and simultaneously activated the adaptive immune system to fight even distant metastases. The results could improve the treatment of superficial tumors such as melanoma and breast cancer.
from Women's Health News -- ScienceDaily https://ift.tt/Gj2AF3k
from Women's Health News -- ScienceDaily https://ift.tt/Gj2AF3k
New combination immunotherapy for melanoma and breast cancer
A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod. This combination showed promising results in topically accessible tumors like melanoma and breast cancer models: The therapy led to the death of tumor cells at the treated sites and simultaneously activated the adaptive immune system to fight even distant metastases. The results could improve the treatment of superficial tumors such as melanoma and breast cancer.
from Breast Cancer News -- ScienceDaily https://ift.tt/Gj2AF3k
from Breast Cancer News -- ScienceDaily https://ift.tt/Gj2AF3k
Drug candidate eliminates breast cancer tumors in mice in a single dose
Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment typically involves surgery and follow-up hormone therapy, but late effects of these treatments include osteoporosis, sexual dysfunction and blood clots. Now, researchers have created a novel treatment that eliminated small breast tumors and significantly shrank large tumors in mice in a single dose, without problematic side effects.
from Breast Cancer News -- ScienceDaily https://ift.tt/mt98gEp
from Breast Cancer News -- ScienceDaily https://ift.tt/mt98gEp
Drug candidate eliminates breast cancer tumors in mice in a single dose
Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment typically involves surgery and follow-up hormone therapy, but late effects of these treatments include osteoporosis, sexual dysfunction and blood clots. Now, researchers have created a novel treatment that eliminated small breast tumors and significantly shrank large tumors in mice in a single dose, without problematic side effects.
from Women's Health News -- ScienceDaily https://ift.tt/mt98gEp
from Women's Health News -- ScienceDaily https://ift.tt/mt98gEp
Tuesday, January 21, 2025
Telephone therapy reduces fatigue interference with activities, mood and cognition for metastatic breast cancer survivors
A clinical trial demonstrates the effectiveness of telephone-delivered acceptance and commitment therapy (ACT) in reducing fatigue's interference with functioning and improving the quality of life for survivors of metastatic breast cancer. The ACT intervention helped study participants to fall asleep with greater ease. Fatigue remains a significant challenge for these survivors, affecting up to 63 percent of patients and severely impacting daily functioning.
from Breast Cancer News -- ScienceDaily https://ift.tt/ESKTyXU
from Breast Cancer News -- ScienceDaily https://ift.tt/ESKTyXU
Saturday, January 18, 2025
Rotavirus protein NSP4 manipulates gastrointestinal disease severity
Researchers have improved our understanding of how rotavirus, the most common cause of acute gastroenteritis in children, makes people sick. The study is among the first to show that the rotavirus protein NSP4 is both necessary and sufficient for multiple aspects of rotavirus infection by disrupting calcium signaling not only within infected cells but also in nearby uninfected cells. These disruptions in calcium signaling affect rotavirus disease severity, providing new insights into how NSP4's function influences rotavirus virulence. The findings suggest that manipulating NSP4 could lead to new strategies to prevent or treat rotavirus infections.
from Women's Health News -- ScienceDaily https://ift.tt/xXwb71i
from Women's Health News -- ScienceDaily https://ift.tt/xXwb71i
Friday, January 17, 2025
Drug in clinical trials for breast cancer could also treat some blood cancers
Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.
from Breast Cancer News -- ScienceDaily https://ift.tt/RCYGp5Q
from Breast Cancer News -- ScienceDaily https://ift.tt/RCYGp5Q
Cancer mortality continues to drop despite rising incidence in women
The American Cancer Society (ACS) today released Cancer Statistics, 2025, the organization's annual report on cancer facts and trends. The new findings show the cancer mortality rate declined by 34% from 1991 to 2022 in the United States, averting approximately 4.5 million deaths. However, this steady progress is jeopardized by increasing incidence for many cancer types, especially among women and younger adults, shifting the burden of disease. For example, incidence rates in women 50-64 years of age have surpassed those in men, and rates in women under 50 are now 82% higher than their male counterparts, up from 51% in 2002.
from Women's Health News -- ScienceDaily https://ift.tt/dXi7UFP
from Women's Health News -- ScienceDaily https://ift.tt/dXi7UFP
Wednesday, January 8, 2025
Researchers resolve uncertainty in BRCA2 testing, improving cancer risk assessment and patient care
Findings from a multi-institutional, international study have significantly advanced the understanding of genetic alterations in the BRCA2 gene, a key player in hereditary cancer risk.
from Breast Cancer News -- ScienceDaily https://ift.tt/Dg4wEQZ
from Breast Cancer News -- ScienceDaily https://ift.tt/Dg4wEQZ
Monday, January 6, 2025
Researchers boost chemotherapy uptake in breast cancer treatment with localized magnetic fields
Researchers have developed a non-invasive method to improve the effectiveness of chemotherapy while reducing its harmful side effects. By applying brief, localized pulses of magnetic fields, the team demonstrated a significant increase in the uptake of doxorubicin (DOX), a widely used chemotherapy drug, into breast cancer cells, with minimal impact on healthy tissues.
from Breast Cancer News -- ScienceDaily https://ift.tt/nla37qw
from Breast Cancer News -- ScienceDaily https://ift.tt/nla37qw
Researchers boost chemotherapy uptake in breast cancer treatment with localized magnetic fields
Researchers have developed a non-invasive method to improve the effectiveness of chemotherapy while reducing its harmful side effects. By applying brief, localized pulses of magnetic fields, the team demonstrated a significant increase in the uptake of doxorubicin (DOX), a widely used chemotherapy drug, into breast cancer cells, with minimal impact on healthy tissues.
from Women's Health News -- ScienceDaily https://ift.tt/nla37qw
from Women's Health News -- ScienceDaily https://ift.tt/nla37qw
Saturday, January 4, 2025
Approaches against metastatic breast cancer: mini-tumors from circulating cancer cells
Tumor cells circulating in the blood are the 'germ cells' of breast cancer metastases. They are very rare and could not be propagated in the culture dish until now, which made research into therapy resistance difficult. A team has now succeeded for the first time in cultivating stable tumor organoids directly from blood samples of breast cancer patients. Using these mini-tumors, the researchers were able to decipher a molecular signaling pathway that ensures the cancer cells' survival and resistance to therapy. With this knowledge, the team was able to develop an approach to specifically eliminate these tumor cells in lab experiments.
from Breast Cancer News -- ScienceDaily https://ift.tt/Rafn5pw
from Breast Cancer News -- ScienceDaily https://ift.tt/Rafn5pw
Friday, January 3, 2025
Patients with heart disease may be at increased risk for advanced breast cancer
Patients diagnosed with late-stage or metastatic breast cancer have a statistically significant increased risk of pre-diagnosis cardiovascular disease (CVD) compared to those with early-stage cancer at diagnosis.
from Breast Cancer News -- ScienceDaily https://ift.tt/5O8fIXk
from Breast Cancer News -- ScienceDaily https://ift.tt/5O8fIXk
Patients with heart disease may be at increased risk for advanced breast cancer
Patients diagnosed with late-stage or metastatic breast cancer have a statistically significant increased risk of pre-diagnosis cardiovascular disease (CVD) compared to those with early-stage cancer at diagnosis.
from Women's Health News -- ScienceDaily https://ift.tt/5O8fIXk
from Women's Health News -- ScienceDaily https://ift.tt/5O8fIXk
Wednesday, January 1, 2025
Achieving bone regeneration and adhesion with harmless visible light
A team develops an innovative injectable hydrogel for bone regeneration, addressing the limitations of traditional bone grafts and adhesion methods.
from Women's Health News -- ScienceDaily https://ift.tt/u0biAyq
from Women's Health News -- ScienceDaily https://ift.tt/u0biAyq
Subscribe to:
Posts (Atom)